Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Phase II study of MGL-3196 in NASH achieves liver biopsy endpoints at 36 weeks

June 1, 2018

Researchers from U.S. patent 5-HT1F receptor agonists

May 31, 2018

Atox initiates phase II trial of reltecimod in acute kidney injury

May 30, 2018

CLCF1 biomarker may help diagnose delayed graft function in kidney transplantation

May 25, 2018

Novo Nordisk licenses EPGN-696 from Epigen

May 25, 2018

VFMCRP and Cara sign development and commercialization agreement for CR-845

May 23, 2018

FDA approves Lokelma for hyperkalemia

May 22, 2018

Bayer patents new vasopressin V1A and V2 receptor antagonists

May 17, 2018

Dimerix announces plans for phase II trials with DMX-200 in chronic kidney disease

May 16, 2018

Promising in vivo results for EP-055, a potential nonhormonal male contraceptive

May 11, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...